Planet 13 Holdings PLNH
OTC PLNH
$0.16 +0.01 (+5.63%)
As of: Aug 21, 2026 · 3:59 PM EDT

Planet 13 Holdings (PLNH) Total Non-Current Liabilities (2020 - 2026)

Planet 13 Holdings (PLNH) posted quarterly Total Non-Current Liabilities of $101.9 million for Q1 2026, up 38.23% year-over-year from $73.7 million in Q1 2025, and up 49.65% quarter-over-quarter from $68.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has reported Total Non-Current Liabilities for 7 consecutive years, with $101.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 38.23% year-over-year to $101.9 million; the TTM figure through Mar 2026 stood at $101.9 million (up 38.23% YoY), while the FY2025 annual figure was $68.1 million, down 8.82% from the prior year.
  • Total Non-Current Liabilities advanced to $101.9 million in Q1 2026 per PLNH's latest filing, from $68.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $102.6 million in Q3 2025 and bottomed at $35.5 million in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $61.3 million across 5 years, with a median of $45.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 671.38% — and 2025, when it declined 9.71%.
  • Planet 13 Holdings' Total Non-Current Liabilities stood at $42.7 million in 2022, then climbed by 3.19% to $44.1 million in 2023, then jumped by 69.36% to $74.7 million in 2024, then slipped by 8.82% to $68.1 million in 2025, then jumped by 49.65% to $101.9 million in 2026.
  • Business Quant data shows PLNH's Total Non-Current Liabilities at $101.9 million in Q1 2026, $68.1 million in Q4 2025, and $102.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 16.45 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 334.00 Mn
10 Planet 13 Holdings 52.64 Mn 36.16 Mn 12.32 Mn 65.37 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 65.37 Mn
Mar 31, 2026 101.92 Mn
Dec 31, 2025 68.11 Mn
Sep 30, 2025 102.65 Mn
Jun 30, 2025 76.15 Mn
Mar 31, 2025 73.74 Mn
Dec 31, 2024 74.70 Mn
Sep 30, 2024 92.25 Mn
Jun 30, 2024 84.34 Mn
Mar 31, 2024 45.62 Mn
Dec 31, 2023 44.11 Mn
Sep 30, 2023 41.52 Mn
Jun 30, 2023 40.44 Mn
Mar 31, 2023 40.95 Mn
Dec 31, 2022 42.74 Mn
Sep 30, 2022 35.88 Mn
Jun 30, 2022 35.50 Mn
Mar 31, 2022 41.17 Mn
Dec 31, 2021 43.07 Mn
Mar 31, 2021 -7.21 Mn